The following primary antibodies were employed (dilution): ZO1 (1:1000,
ab96587, Abcam, USA), occludin (1:1000,
ab167161, Abcam, USA), claudin-1 (1:1000,
ab15098, Abcam, USA), IκBα (1:2000, 4812, Cell Signaling Technology, USA), p-IκBα (1:2000, 2859, Cell Signaling Technology, USA), NF-κB p65 (1:1000,
ab16502, Abcam, USA), monocyte chemotactic protein-1 (MCP-1, 1:1000,
ab7202; Abcam, USA), cyclooxygenase-2 (COX-2, 1:1000,
ab62331; Abcam, USA), Keap1 (1:1000,
ab139729, Abcam, USA), Nrf2 (1:1000,
ab31163, Abcam, USA), heme oxygenase 1 (HO-1, 1:2000,
ab68477, Abcam, USA), catalase (1:1000,
ab52477, Abcam, USA), NAD(P)H quinone dehydrogenase 1 (NQO1, 1:1000,
ab28947, Abcam, USA), α smooth muscle actin (α-SMA, 1:300,
ab7817, Abcam, USA), collagen I (1:5000,
ab34710, Abcam, USA), and fibronectin (1:1000,
ab2413, Abcam, USA). Western blot analysis was performed as previously described
24 (link),26 (link),27 (link). Blots were obtained with ECL reagent and protein concentrations were normalized by actin expression. Specific bands indicating target proteins were analyzed using ImageJ 1.48 v software.
Chen L., Chen D.Q., Liu J.R., Zhang J., Vaziri N.D., Zhuang S., Chen H., Feng Y.L., Guo Y, & Zhao Y.Y. (2019). Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis. Experimental & Molecular Medicine, 51(3), 38.